Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;24(2):S11-6.
doi: 10.1097/01.hjh.0000220098.12154.88.

Circadian Rhythm of Blood Pressure and the Relation to Cardiovascular Events

Affiliations
Review

Circadian Rhythm of Blood Pressure and the Relation to Cardiovascular Events

Thomas D Giles. J Hypertens Suppl. .

Abstract

Incidences of potentially life-threatening cardiovascular events display a diurnal pattern, tending to be higher in the morning than at other times of day. The recording of blood pressure at pre-defined intervals under everyday circumstances is facilitated by ambulatory blood pressure monitoring (ABPM). This technique shows that systolic and diastolic blood pressures display a circadian rhythm in most individuals. Typically, at the end of the night on arousal, blood pressure surges. This surge coincides with increased cardiovascular events. A recent prospective study conducted in Japan, where the incidence of stroke is high, provides further evidence for the link between cardiovascular events and morning blood pressure surge. Prevalence of both silent ischaemic events and multiple cerebrovascular infarcts was highest among the elderly subjects studied, with the largest increase in blood pressure on awakening. An increased risk of cardiovascular morbidity and mortality is also seen in 'non-dippers' (i.e. individuals in whom the normal nocturnal fall in blood pressure is absent or blunted). ABPM is superior to clinic blood pressure in predicting cardiovascular morbidity and mortality, and this suggests that 24-h blood pressure control may be necessary to gain complete benefit from blood pressure-lowering therapy. Antihypertensive agents with a long duration of action have the potential to provide blood pressure control throughout the dosing interval and thus cover the critical early morning period when the blood pressure surges. Clinical studies that have compared telmisartan with shorter-acting angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors demonstrate that telmisartan has a sustained duration of action, with proven efficacy over the entire 24-h period between doses, including the critical early morning period.

Similar articles

See all similar articles

Cited by 16 articles

  • Variability in Sleep Patterns: an Emerging Risk Factor for Hypertension.
    Makarem N, Zuraikat FM, Aggarwal B, Jelic S, St-Onge MP. Makarem N, et al. Curr Hypertens Rep. 2020 Feb 21;22(2):19. doi: 10.1007/s11906-020-1025-9. Curr Hypertens Rep. 2020. PMID: 32086595 Review.
  • Blood pressure monitoring in sleep: time to wake up.
    Kwon Y, Stafford PL, Lim DC, Park S, Kim SH, Berry RB, Calhoun DA. Kwon Y, et al. Blood Press Monit. 2020 Apr;25(2):61-68. doi: 10.1097/MBP.0000000000000426. Blood Press Monit. 2020. PMID: 31855900
  • Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration.
    Noordam R, Bos MM, Wang H, Winkler TW, Bentley AR, Kilpeläinen TO, de Vries PS, Sung YJ, Schwander K, Cade BE, Manning A, Aschard H, Brown MR, Chen H, Franceschini N, Musani SK, Richard M, Vojinovic D, Aslibekyan S, Bartz TM, de Las Fuentes L, Feitosa M, Horimoto AR, Ilkov M, Kho M, Kraja A, Li C, Lim E, Liu Y, Mook-Kanamori DO, Rankinen T, Tajuddin SM, van der Spek A, Wang Z, Marten J, Laville V, Alver M, Evangelou E, Graff ME, He M, Kühnel B, Lyytikäinen LP, Marques-Vidal P, Nolte IM, Palmer ND, Rauramaa R, Shu XO, Snieder H, Weiss S, Wen W, Yanek LR, Adolfo C, Ballantyne C, Bielak L, Biermasz NR, Boerwinkle E, Dimou N, Eiriksdottir G, Gao C, Gharib SA, Gottlieb DJ, Haba-Rubio J, Harris TB, Heikkinen S, Heinzer R, Hixson JE, Homuth G, Ikram MA, Komulainen P, Krieger JE, Lee J, Liu J, Lohman KK, Luik AI, Mägi R, Martin LW, Meitinger T, Metspalu A, Milaneschi Y, Nalls MA, O'Connell J, Peters A, Peyser P, Raitakari OT, Reiner AP, Rensen PCN, Rice TK, Rich SS, Roenneberg T, Rotter JI, Schreiner PJ, Shikany J, Sidney SS, Sims M, Sitlani CM, Sofer T, Strauch K, Swertz MA, Taylor KD, Uitterlinden AG, van Duijn CM, Völzke H, Waldenberger M, Wallance RB, van Dijk KW, Yu C, Zonderman AB, Becker DM, Elliott P, Esko T, Gieger C, Grabe HJ, Lakka TA, Lehtimäki T, North KE, Penninx BWJH, Vollenweider P, Wagenknecht LE, Wu T, Xiang YB, Zheng W, Arnett DK, Bouchard C, Evans MK, Gudnason V, Kardia S, Kelly TN, Kritchevsky SB, Loos RJF, Pereira AC, Province M, Psaty BM, Rotimi C, Zhu X, Amin N, Cupples LA, Fornage M, Fox EF, Guo X, Gauderman WJ, Rice K, Kooperberg C, Munroe PB, Liu CT, Morrison AC, Rao DC, van Heemst D, Redline S. Noordam R, et al. Nat Commun. 2019 Nov 12;10(1):5121. doi: 10.1038/s41467-019-12958-0. Nat Commun. 2019. PMID: 31719535 Free PMC article.
  • Shift Work and the Risk of Cardiovascular Diseases and Metabolic Syndrome Among Jordanian Employees.
    Abu Farha R, Alefishat E. Abu Farha R, et al. Oman Med J. 2018 May;33(3):235-242. doi: 10.5001/omj.2018.43. Oman Med J. 2018. PMID: 29896332 Free PMC article.
  • Renal denervation attenuates hypertension but not salt sensitivity in ETB receptor-deficient rats.
    Becker BK, Feagans AC, Chen D, Kasztan M, Jin C, Speed JS, Pollock JS, Pollock DM. Becker BK, et al. Am J Physiol Regul Integr Comp Physiol. 2017 Oct 1;313(4):R425-R437. doi: 10.1152/ajpregu.00174.2017. Epub 2017 Jul 12. Am J Physiol Regul Integr Comp Physiol. 2017. PMID: 28701323 Free PMC article.
See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback